ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.92
-0.02 (-0.34%)
At close: Jun 26, 2026, 4:00 PM EDT
6.02
+0.10 (1.69%)
After-hours: Jun 26, 2026, 4:10 PM EDT
ImageneBio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ImageneBio stock have an average target of 13, with a low estimate of 2.00 and a high estimate of 24. The average target predicts an increase of 119.59% from the current stock price of 5.92.
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for ImageneBio stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Maintains $2 | Sell | Maintains | $2 | -66.22% | May 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $30 → $24 | Buy | Maintains | $30 → $24 | +305.41% | May 8, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
n/a
from 800.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-4.48
from -9.64
EPS Next Year
-3.98
from -4.48
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.57 | -3.79 | |
| Avg | -4.48 | -3.98 | |
| Low | -5.39 | -4.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.